
|Podcasts|May 25, 2022
Pharmacy Focus: Independent Rx Forum- DIR Fees and Recent Rulemaking From CMS
Independent pharmacies' constant battle over the years to try and get relief for NCPA members on these retroactive DIR fees have been really the number one issue.
Advertisement
Today's episode features Ronna Hauser and Karry La Violette from NCPA who discuss the most recent rules from CMS and how it will impact DIR fees in the pharmacy landscape.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Lerodalcibep for Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia
2
Once-Weekly Retatrutide Reduces Weight and Knee Pain in Patients With Obesity and Osteoarthritis
3
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
4
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
5

















































































































































































































